Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV.
Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV
Diabetes. 2019 Mar;68(3):637-647. doi: 10.2337/db18-1064. Epub 2019 Jan 9.
Patients with diabetes often develop gastrointestinal motor problems, including gastroparesis. Previous studies have suggested this gastric motor disorder was a consequence of an enteric neuropathy. Disruptions in interstitial cells of Cajal (ICC) have also been reported. A thorough examination of functional changes in gastric motor activity during diabetes has not yet been performed. We comprehensively examined the gastric antrums of mice using functional, morphological, and molecular techniques to determine the pathophysiological consequences in this type 2 diabetic animal model. Video analysis and isometric force measurements revealed higher frequency and less robust antral contractions in mice compared with controls. Electrical pacemaker activity was reduced in amplitude and increased in frequency. Populations of enteric neurons, ICC, and platelet-derived growth factor receptor α cells were unchanged. Analysis of components of the prostaglandin pathway revealed upregulation of multiple enzymes and receptors. Prostaglandin-endoperoxide synthase-2 inhibition increased slow wave amplitudes and reduced frequency of diabetic antrums. In conclusion, gastric pacemaker and contractile activity is disordered in type 2 diabetic mice, and this appears to be a consequence of excessive prostaglandin signaling. Inhibition of prostaglandin synthesis may provide a novel treatment for diabetic gastric motility disorders.
糖尿病患者常出现胃肠道动力问题,包括胃轻瘫。先前的研究表明,这种胃动力障碍是肠神经病变的结果。也有报道称 Cajal 间质细胞(ICC)存在紊乱。尚未对糖尿病期间胃动力活动的功能变化进行全面检查。我们使用功能、形态和分子技术全面检查了小鼠的胃窦,以确定这种 2 型糖尿病动物模型的病理生理后果。视频分析和等长力测量显示,与对照组相比, 小鼠的胃窦收缩频率更高,幅度更小。电起搏器活动的幅度降低,频率增加。肠神经元、ICC 和血小板衍生生长因子受体 α 细胞的数量没有变化。对前列腺素途径成分的分析显示,多种酶和受体上调。前列腺素-环氧合酶-2 抑制剂增加了糖尿病胃窦的慢波幅度并降低了频率。总之,2 型糖尿病小鼠的胃起搏和收缩活动紊乱,这似乎是前列腺素信号过度的结果。抑制前列腺素合成可能为治疗糖尿病性胃动力障碍提供一种新的方法。